The health and wellbeing of Cannabis Europa attendees, partners, speakers and the overall community is our top priority. Due to the growing concern around the coronavirus (COVID-19), Cannabis Europa will be going digital this year instead.
On the 22nd /23rd June, PP Live will bring you superb content, targeted virtual networking and engaging digital experiences - not just for Europa but there will be streams for every global region. All at the touch of a button.
Cannabis Europa and PP LIVE will feature:
Live-streamed panels and keynotes bringing audiences closer to the content.
Interactive educational workshops that hear from you and ‘Ask an expert’ sessions to address issues that affect your business.
Targeted networking that suggests virtual meetups that are right for you and lifetime access to talks and panels.
Stay tuned for more details…
Ps. We are offering full refunds for all ticket holders. Get in touch with us at firstname.lastname@example.org for more information.
OUR VIRTUAL GLOBAL GATHERING
Pioneering researchers and academics are overhauling our understanding of medical cannabis. As the knowledge base and data set develops, a seismic shift in public opinion is occurring at a global scale, resulting in progressive legislation, high-quality cannabis-based medicines and transformative commercial opportunities.
Cannabis continues to make headlines across Europe as new countries look to push forward medical cannabis programmes and unlock the societal and commercial potential of this formerly stigmatised plant. At the other end of the spectrum, consumer interest in CBD continues to skyrocket, disrupting mainstream industries from food and drink to wellness and beauty.
We invite you to join policymakers, pioneers and innovators on June 22 - 23, 2020 to help shape the future of medical cannabis. Watch this space for more information.
THE NEXT STEP IN EUROPE
Rapidly emerging technological and political developments are triggering new conversations in Europe are raising pertinent questions:
How will we view cannabis in 2050?
Will cannabinoid-based medicines be another standard in modern healthcare systems?
Will CBD remain a novel food in the EU?
Will Luxembourg become a model for the regulation of cannabis like Denmark has become for medical cannabis?
In June, key stakeholders and operators will provide their insights into these key questions, addressing the challenges and opportunities presented by the unique market.
<div style="text-align: center; font-size:22px;">
Form submitted. Thank you!